Laura Lovett

The new tool will cater to patients with or without insurance, and the company says that "most visits" will cost $20. 

The new project will be using the company's accumulated data set to build an autonomous mental health platform. 

The partners announced that they are putting out a request for clinical trial proposals in the areas of dermatology, gastroenterology, pulmonology, endocrinology, ophthalmology, inflammatory diseases, neurology, women’s health and rare diseases. 

Stakeholders at today's DTx East event in Boston discuss digital therapeutic risk assessment and management. 

The company plans to expand its technology offerings. 

Boston Medical Center CEO Kate Walsh and Christiana Health CEO Dr. Janice Nevin discuss the future of virtual care in supporting vulnerable populations. 

The new funding comes just a few months after it announced a $6.6 million Series A investment. 

The new money will help the company expand to the US and cater to more conditions. 

The new round was led by Acton Capital with participation from SE Health. 

Sanofi's deal with Abbott will be focusing on the diabetes space, while its deal with Happify will be looking at treating MS symptoms using a digital therapeutic.